PreveCeutical Medical Inc (CSE:PREV) (OTCQB:PRVCF) (FRA:18H) announced Wednesday the successful laboratory development of a cannabinoid Sol-Gel formulation (SARS-CoV-2 Sol-Gel) as a potential prevention and treatment for COVID-19.
Independent scientific literature, the company noted, has reported that high CBD strains could potentially have beneficial properties for the prevention/treatment of the SARS-CoV-2 infection.
PreveCeutical cited a peer-reviewed hypothesis paper titled, "The potential of cannabidiol in the COVID-19 pandemic," published in May by the British Journal of Pharmacology. There is a second article titled, "Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA," published online in September.
READ: PreveCeutical files patent application in Australia seeking protection for cannabinoid formulations to prevent and treat COVID-19
PreveCeutical has successfully infused a high CBD strain into a proprietary Sol-Gel formulation, which is intended for self-administration using a Sol-Gel nasal spray device. This formulation is now ready for preclinical evaluation for pharmaceutical and nutraceutical applications.
The company also has filed a patent application to protect the intellectual property arising from the COVID-19 CBD Sol-Gel formulation.
"We are very pleased that a high CBD strain-specific Sol-Gel has been successfully formulated with the potential to address COVID-19,” said CEO Stephen Van Deventer in a statement.
"The non-invasive, Sol-Gel delivery system, licensed from UniQuest Pty Ltd, is uniquely designed to deliver micelle loaded cannabinoids through trans-mucosal routes, rather than conventional oral routes. This delivery method will avoid hepatic metabolism and allow targeted delivery at the site of action. We will now move towards the start of preclinical assessment with the intention to rapidly move into the clinical trials process."
The company said it is not making any express or implied claims that its product has the ability to eliminate, cure, or contain COVID-19 at this time.
Contact the author: firstname.lastname@example.org
Follow him on Twitter @PatrickMGraham